Not too long ago, Serena Williams was apparently practicing drills once more on a sunny afternoon—not on the well-known blue courts of the U.S. Open, but on a peaceful track encircled by palm palms. Compared to the boisterous stadiums where she used to overwhelm opponents for decades, the scene appeared almost serene. However, the resolve seemed strikingly familiar.
The term “second act” typically refers to slowing down after a lengthy career. It appears to have a distinct meaning for Serena Williams. She hasn’t been forced to the sidelines by her retirement from professional tennis. If anything, it has launched a new chapter focused on curiosity, health, and an unexpected amount of exploration. Additionally, one specific modification has generated unusual public debate.
| Category | Information |
|---|---|
| Full Name | Serena Jameka Williams |
| Born | September 26, 1981 |
| Age | 44 |
| Nationality | American |
| Profession | Former Professional Tennis Player, Entrepreneur |
| Grand Slam Titles | 23 Singles Titles |
| Recent Health Transformation | Lost approximately 31–34 pounds (2025–2026) |
| Method | GLP-1 weight-loss medication with Ro telehealth platform |
| Health Outcomes | Lower cholesterol, improved blood sugar, reduced joint pain |
| Current Focus | Health, family life, business ventures |
| Reference Website |
Williams disclosed that she lost between 31 and 34 pounds over the course of the previous year, in part thanks to GLP-1 weight-loss medication, which has quickly emerged as one of the most talked-about medical advancements in contemporary healthcare. For Williams, the goal wasn’t vanity. It was a more useful thing. She encountered health problems with the birth of her second child, which she had not experienced during her tennis career.
The levels of high cholesterol started to rise. After working out, joint soreness persisted. Even everyday motion felt more difficult than it used to. That change must have been uncomfortable for an athlete used to rapid speed and endurance. Athletes may have a different retirement experience than the rest of us.
Their bodies have been subjected to rigorous regimens for decades, including pre-dawn training sessions, gram-by-gram diet plans, and recovery regimens created by teams of experts. That framework vanishes practically instantly when the competition is ended. That shift is difficult for some athletes. It appears that Williams saw it as just another task.
She started integrating the treatment into an existing rigorous regimen of exercise and diet after partnering with Ro, a telemedicine company that provides GLP-1 drugs like Zepbound. However, she took care to highlight a point that occasionally goes overlooked in the news. The drug wasn’t a quick fix.
In interviews, she clarified, “It wasn’t a magic switch.” The daily routines—long workouts, strict nutrition, and unwavering focus—remained mostly same despite the medication’s assistance in controlling hunger and metabolism. She seemed to approach the procedure with the same analytical perspective that characterized her tennis career as I saw her discuss it.
Williams has long been regarded as a player who paid close attention to her game. She continually experimented with technique, analyzed opponents’ weaknesses, and modified her plan in the middle of a game. Her health transformation seems to be a continuation of that way of thinking in certain aspects. Instead of evaluating a backhand return, she began analyzing metabolic wellness.
Williams said even she was taken aback by the outcomes. She reports that her blood sugar stabilized, her cholesterol levels decreased, and her chronic joint pain subsided, making daily movement more comfortable. Alongside the bodily changes came something less quantifiable but possibly equally significant: a revitalized sensation of vitality.
One observer commented, “It’s hard not to notice,” after viewing recent pictures of Williams training once more. The former champion seems lighter both psychologically and physically. Naturally, the public’s response has been nuanced.
GLP-1 drugs are now somewhat of a cultural hot potato. They were first created to treat diabetes, but they are now frequently used to help patients manage their weight, especially those who are obese or have metabolic health problems. The medications run the risk of becoming lifestyle shortcuts, according to some detractors.
Others see them not as scientific discoveries but as long-overdue medical advances for ailments that have long been stigmatized. Interestingly, Williams appears to be conscious of the tension. She has attempted to refute the notion that utilizing medical equipment somehow compromises discipline by being transparent about her experience. She explained that the drug just increased the efficiency of hard effort.
Many others going through similar struggles can find resonance in that viewpoint. Millions of adults experience postpartum weight fluctuations, midlife metabolic changes, and long-term health problems when they find that their old routines no longer yield the same outcomes.
Williams encountered some of those same realities despite her remarkable athletic achievements. Her candor has also spurred discussion about how athletes’ roles change after retirement. For many years, the general public assumed that former sports stars would discreetly transition into endorsement deals or commentary positions.
Williams seems to be going in a different direction. She continues to be active in philanthropy, business endeavors, and family life while also investigating personal issues that seem to go beyond rivalry. She recently made an almost casual suggestion that she might train for a half-marathon, which would entail months of endurance training.
The transition to long-distance running would be an intriguing change for someone who previously built a career on short, explosive bursts of power on a tennis court. Those who followed Williams’ tennis career, however, may notice a recurring pattern. She seldom complied with expectations.
